Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
HwEjcUR47cPwLqtN